No Data
No Data
Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Deutsche Bank Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $18
JPMorgan Adjusts Cellebrite DI Price Target to $17 From $15, Maintains Overweight Rating
Cellebrite DI Is Maintained at Overweight by JP Morgan
Express News | Cellebrite DI Shares Are Trading Higher After Multiple Firms Raised Their Respective Price Targets on the Stock
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
loading...
No Data